| 0.03 Data as of May 20 |  0.00 / 0.00%Today’s Change | 0.01 Today|||52-Week Range 0.06 | +100.00% Year-to-Date |
| Previous close | 0.03 |
| Today’s open | 0.03 |
| Day’s range | -- - -- |
| Volume | 469,388 |
| Average volume (3 months) | 1,286,280 |
| Market cap | $6.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +57.89% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -62.32% |
| P/E ratio | NM |
| Price/Sales | 146.36 |
| Price/Book | -- |
| No competitors data available. |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $17.5K |
| Annual profit (last year) | -$4.7M |
| Net profit margin | -26,878.61% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Mike Tomas, MBA |
Chief Scientific Officer & Director Kristin C. Comella |
Corporate headquarters Sunrise, Florida |
.
